Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Weingart - K08HS11644 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | FED |
| Blue Cross Blue Shield | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a study to better understand the nature and extent of adverse drug events (ADEs), defined as injuries due to prescription medications, in primary care. We will study whether PatientSite (an internet-based communication program for patients and health care providers) can improve clinicians' ability to detect adverse drug events among primary care patients and to mitigate the consequences by sending electronic queries to patients after they receive new medication prescriptions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MedCheck | Experimental | Electronic medication safety queries via PatientSite portal |
|
| Usual care | No Intervention | No electronic medication safety messages via PatientSite portal |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Medcheck message | Other | Participants selected at random will receive one email message asking them questions about their prescription which will be forwarded to their physician |
|
| Measure | Description | Time Frame |
|---|---|---|
| To prevent adverse drug events with PatientSite. | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Improve patient satisfaction | 3 years | |
| better utilization of services | 3 years | |
| improve patient-clinician communication |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Saul N Weingart, MD, PhD | Dana-Farber Cancer Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23965840 | Derived | Weingart SN, Carbo A, Tess A, Chiappetta L, Tutkus S, Morway L, Toth M, Davis RB, Phillips RS, Bates DW. Using a patient internet portal to prevent adverse drug events: a randomized, controlled trial. J Patient Saf. 2013 Sep;9(3):169-75. doi: 10.1097/PTS.0b013e31829e4b95. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 years |